Efficacy and safety of adding a fourth oral antidiabetic drug versus metformin dose escalation in patients with type 2 diabetes inadequately controlled on triple oral combination therapy ( <scp>EFFORT</scp> ): A 24‐week, randomized, open‐label, multi

Oral quadruple therapy achieved greater glycaemic and metabolic improvement without compromising safety, compared with metformin uptitration, supporting its role as an intensification strategy.

Authors

Institutions

Publication Details

Journal
Diabetes Obesity and Metabolism
Published
2026-02-03
DOI
https://doi.org/10.1111/dom.70527
Primary Topic
Diabetes Treatment and Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Efficacy and safety of adding a fourth oral antidiabetic drug versus metformin dose escalation in patients with type 2 diabetes inadequately controlled on triple oral combination therapy ( EFFORT ): A 24‐week, randomized, open‐label, multi

Ju-Young Moon, So Ra Kim, SIN GON KIM, B W Lee et al.
Diabetes Obesity and Metabolism
Diabetes Treatment and Management
article

Efficacy and safety of adding a fourth oral antidiabetic drug versus metformin dose escalation in patients with type 2 diabetes inadequately controlled on triple oral combination therapy ( EFFORT ): A 24‐week, randomized, open‐label, multi

Ju-Young Moon, So Ra Kim, SIN GON KIM, B W Lee, Soo‐Kyung Kim, Jae Myung Yu, Jun Hwa Hong, Hyuk‐Sang Kwon, Jung Hwan Park, Bong‐Soo Cha
article en

Abstract

Oral quadruple therapy achieved greater glycaemic and metabolic improvement without compromising safety, compared with metformin uptitration, supporting its role as an intensification strategy.

Diabetes Obesity and MetabolismVol. 28(4)
Yonsei University (KR), Korea University (KR), Eulji University (KR), Hallym University Kangnam Sacred Heart Hospital (KR), The Catholic University of Korea Yeouido St. Mary's Hospital (KR), CHA University Bundang Medical Center (KR), Yeungnam University Medical Center (KR), Hanyang University (KR), Yeungnam University (KR)
Good health and well-being
Openalex Percentile: Top 70%
Diabetes Treatment and Management
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Efficacy and safety of adding a fourth oral antidiabetic drug versus metformin dose escalation in patients with type 2 diabetes inadequately controlled on triple oral combination therapy ( <scp>EFFORT</scp> ): A 24‐week, randomized, open‐label, multi — Ju-Young Moon, So Ra Kim, et al. · Diabetes Obesity and Metabolism (2026) | TGRS Research Map | TGRS